Indrayani Biotech Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Indrayani Biotech Ltd. on BSE

Load latest

Indrayani Biotech Ltd.

13 Apr 2023

11.30

-2.42%

Corp. Note

INDRAYANI BIOTECH LTD. - 526445 - Format of the Annual Disclosure to be made by an …

BSE India

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company INDRAYANI BIOTECH LTD. 2 CIN NO. L40100TN1992PLC129301 3 Report filed for FY 2022-2023 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* Not Applicable 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)Not Applicable Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Mamtha MadeshDesignation :-Compliance Officer Name of the Chief Financial Officer :- Vinayaka Bodala Designation : -Chief Financial Officer Date: 13/04/2023

pdf

Indrayani Biotech Ltd.

08 Apr 2023

11.30

-2.42%

Company Update

INDRAYANI BIOTECH LTD. - 526445 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we are enclosing herewith the copy of Certificate received from M/s. Link Intime India Private Limited, the Registrar and Transfer Agent (RTA) of the Company, for the Quarter ended March 31, 2023.

pdf

Indrayani Biotech Ltd.

31 Mar 2023, 05:00PM

11.30

-2.42%

SAST

INDRAYANI BIOTECH LTD. - 526445 - Closure of Trading Window

BSE India

This is to inform you that in terms of Company''s Code of Internal Procedures and Conduct for Prohibition of Insider Trading, 2015, the Trading Window for trading and dealing in securities of the company by the Directors, Designated persons and their immediate relatives shall remain closed from April 01, 2023, till the expiry of 48 hours after the declaration of Audited Financial Results of the Company for the quarter and financial year ended March 31, 2023. All the Directors, Designated Persons, connected persons and their immediate relatives are advised not to deal in the Company''s equity shares during the above said period.

pdf

Indrayani Biotech Ltd.

08 Mar 2023

11.30

-2.42%

Corp. Note

INDRAYANI BIOTECH LTD. - 526445 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015.

pdf

Indrayani Biotech Ltd.

02 Mar 2023

11.30

-2.42%

Company Update

INDRAYANI BIOTECH LTD. - 526445 - Intimation Of Amendment In Code Of Fair Disclosure Of Unpublished …

BSE India

With reference to the announcement as on 01-03-2023, we hereby inform that the Board of Directors at its Meeting held on Tuesday, February 14, 2023 has inter alia, reviewed and approved the amendments in the Code of Fair Disclosure of Unpublished Price Sensitive Information Policy (''''Code of Fair Disclosure'''') of the Company. The said Code of Fair Disclosure is enclosed herewith and is also being hosted on the website of the Company at www.indrayani.com

pdf

Indrayani Biotech Ltd.

01 Mar 2023, 11:09AM

11.30

-2.42%

Company Update

INDRAYANI BIOTECH LTD. - 526445 - Intimation Of Amendment In Code Of Fair Disclosure Of Unpublished …

BSE India

This is to inform that the Board of Directors at its Meeting held on Tuesday, February 14, 2023 has inter alia, reviewed and approved the amendments in the Code of Fair Disclosure of Unpublished Price Sensitive Information Policy (''Code of Fair Disclosure'') of the Company. The said Code of Fair Disclosure is enclosed herewith and is also being hosted on the website of the Company at www.indrayani.com

pdf

Indrayani Biotech Ltd.

16 Feb 2023

11.30

-2.42%

Company Update

INDRAYANI BIOTECH LTD. - 526445 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure …

BSE India

With reference to Corporate announcement dated January 13, 2023, we hereby inform that in connection with IBL Healthcare Limited, a wholly-owned subsidiary of Indrayani Biotech Limited and the Successful resolution applicant of Vaasan Medical Center India Private Limited, the Resolution Professional withdraws the proposal for handling the Operational Management. It may be further noted that IBL Healthcare Limited continues to be the Successful Resolution applicant as declared by the Committee of Creditors.

pdf

Indrayani Biotech Ltd.

15 Feb 2023

11.30

-2.42%

Company Update

INDRAYANI BIOTECH LTD. - 526445 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to the Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith the copy of newspaper publications pertaining to unaudited Financial Results for the quarter ended December 31, 2022 published in Trinity Mirror in English Language and Makkal Kural in Tamil Language on February 15, 2023.

pdf

Indrayani Biotech Ltd.

14 Feb 2023

11.30

-2.42%

Result

INDRAYANI BIOTECH LTD. - 526445 - Unaudited Financial Results For The Quarter And Nine Months Ended …

BSE India

Unaudited Financial Results (Standalone and Consolidated) with the Limited Review Report of the Company for the quarter and Nine months ended December 31, 2022 (Q3), pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

pdf

Indrayani Biotech Ltd.

14 Feb 2023

11.30

-2.42%

Board Meeting

INDRAYANI BIOTECH LTD. - 526445 - Board Meeting Outcome for Board Meeting Outcome For Board Meeting …

BSE India

Unaudited Financial Results (Standalone and Consolidated) with the Limited Review Report of the Company for the quarter and nine-months ended December 31, 2022 (Q3), pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

pdf

Is Indrayani Biotech Ltd. worth buying?

26 Votes:

Buy 73.08%

Sell 11.54%

Hold 15.38%